Skip to main content

Table 3 Comparisons of improvement and complete remission rates among the patient groups

From: Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience

 

HEC

(n = 96)

non-HEC

(n = 31)

p-value

 

Standard doses

(n = 98)

low dose

(n = 29)

p-value

Improvement, n (%)

83 (86%)

22 (71%)

0.048

 

80 (82%)

35 (86%)

0.568

Complete remission, n (%)

36 (38%)

6 (19%)

0.062

 

27 (28%)

15 (52%)

0.015